High mobility group box 1: as a 'testament' mediator

by Maruyama, I, Abeyama, K, Ito, T, Biswas, KK, Kawahara, K, Hashiguchi, T, Yakabe, K, Yamada, S, Wada, H
Published 2005

miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1

by Iwagami, Y, Eguchi, H, Nagano, H, Akita, H, Hama, N, Wada, H, Kawamoto, K, Kobayashi, S, Tomokuni, A, Tomimaru, Y, Mori, M, Doki, Y
Published 2013

NY-ESO-1 antibody as a novel tumour marker of gastric cancer

by Fujiwara, S, Wada, H, Kawada, J, Kawabata, R, Takahashi, T, Fujita, J, Hirao, T, Shibata, K, Makari, Y, Iijima, S, Nishikawa, H, Jungbluth, A A, Nakamura, Y, Kurokawa, Y, Yamasaki, M, Miyata, H, Nakajima, K, Takiguchi, S, Nakayama, E, Mori, M, Doki, Y
Published 2013

MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer

by Hasegawa, S, Eguchi, H, Nagano, H, Konno, M, Tomimaru, Y, Wada, H, Hama, N, Kawamoto, K, Kobayashi, S, Nishida, N, Koseki, J, Nishimura, T, Gotoh, N, Ohno, S, Yabuta, N, Nojima, H, Mori, M, Doki, Y, Ishii, H
Published 2014